Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 12, 2022
Patent Application Number
16480090
Date Filed
January 23, 2018
Patent Citations
Patent Primary Examiner
The present disclosure provides pharmaceutical compositions comprising 2-arylsulfonamido-N-arylacetamide derivatized Stat3 inhibitors and certain pharmaceutically acceptable salts thereof, and methods of their use.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
